Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
50.2M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
45.3M
-
Shares change
-
+2.22M
-
Total reported value, excl. options
-
$1.41B
-
Value change
-
+$61.2M
-
Put/Call ratio
-
2.34
-
Number of buys
-
63
-
Number of sells
-
-62
-
Price
-
$31.13
Significant Holders of Immunocore Holdings plc - ADR (IMCR) as of Q3 2024
169 filings reported holding IMCR - Immunocore Holdings plc - ADR as of Q3 2024.
Immunocore Holdings plc - ADR (IMCR) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.3M shares
of 50.2M outstanding shares and own 90.14% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (7.05M shares), T. Rowe Price Investment Management, Inc. (6.5M shares), RTW INVESTMENTS, LP (4.87M shares), FMR LLC (4.84M shares), PRIMECAP MANAGEMENT CO/CA/ (2.47M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.16M shares), BAKER BROS. ADVISORS LP (1.52M shares), ARMISTICE CAPITAL, LLC (1.26M shares), GENERAL ATLANTIC, L.P. (1.26M shares), and Bellevue Group AG (1.21M shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.